CoChat

Investigating nutrient intake during use of glucagon-like peptide-1 receptor agonist: a cross-sectional study

Open access
Johnson, Brittany, Milstead, Mary, Thomas, Olena, McGlasson, Tyler, Green, Lauren, Kreider, Rachel, Jones, Rachel · 2025 · Frontiers in Nutrition

The DOI matches its Crossref record; 38 of the 38 references it cites were found in a registry or an index.

Abstract

Background: Glucagon-like peptide-1 receptor agonist (GLP-1RA) pharmaceutical interventions have advanced medical treatment for obesity, yet little is known about nutrient intake while using a GLP-1RA. The purpose of this study was to compare nutrient intake while using a GLP-1RA to the Dietary Reference Intakes (DRI). Methods: A cross-sectional study was conducted in a sample of participants who had been using GLP-1RA for at least one month ( N = 69). Participants answered online survey questionnaires and completed a 3-day food record. Descriptive statistics (means, standard deviations) were calculated for all participant demographic characteristics and average 3-day nutrient intakes. Average 3-day nutrient intakes were compared to the DRI using 95% confidence intervals (CI). A Bonferroni correction applied accepted significance at p ≤ 0.00156. One-way ANOVA analysis was conducted to compare the self-reported MyPlate servings to recorded servings from the 3-day food record. Results: Compared to the DRI reference values, participants consumed adequate amounts of B-vitamins, copper, phosphorus, selenium, and zinc. Participants had insufficient intakes of several key nutrients below the DRI, including fiber (14.5 g; CI: 12–17), calcium (863 mg; CI: 756–970), iron (12.1 mg; CI: 11–13), magnesium (266 mg; CI: 236–297), potassium (2,186 mg; CI: 1,969–2,402), choline (305 mg; CI: 268–342), vitamin A (560 mcg RAE; CI: 469–651), vitamin C (51 mg; CI: 41–61), vitamin D (4 mcg; CI: 3–5), vitamin E (9.6 mg; CI: 8–11), and p < 0.00156. Participants overconsumed % calories from fat (39.9%; CI: 38, 42), and saturated fat (26 g; CI: 26, 26), p < 0.00156. Participants did not meet the daily recommended MyPlate servings for fruit, vegetables, grains, or dairy ( p < 0.01). Protein intake (% total calories) was within the AMDR, however based on a g/kg/day, protein intake was significantly under daily needs. Conclusion: Participants on a GLP-1RA are not meeting the DRI for several vital nutrients through their diet or higher protein needs during weight loss. Patient-centered nutritional guidance is essential to optimize health outcomes and prevent unintended health consequences. Future large-scale studies are needed to assess the replicability of these findings and provide custom nutritional guidance for those on a GLP-1RA medication.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.3389/fnut.2025.1566498

Cites

38 of 38 references verified0 citation errors · 0 not checkable

Statistics

Figures

Figure 1 Frequency count categorized three-day average nutrient intake of GLP-1RA participants compared to dietary reference intake.
Figure 1 Frequency count categorized three-day average nutrient intake of GLP-1RA participants compared to dietary reference intake.CC BY · PubMed Central
Figure 2 Categorized average three-day food record of GLP1-RA participants based on Acceptable Macronutrient Distribution Range (AMDR).
Figure 2 Categorized average three-day food record of GLP1-RA participants based on Acceptable Macronutrient Distribution Range (AMDR).CC BY · PubMed Central

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

21 more claims about this paper

Create a free account to see every claim other papers make about this one.

See all claims — free account

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 38 references

Research works printed but not linked: 5

  1. 2024, Obesity and overweight [internet]
  2. 2025, Report on clinical practice guidelines for nutrition in obesity [internet]
  3. 2020, Dietary guidelines for Americans
  4. 2025, ASA24
  5. Wharton, 2021, Managing the gastrointestinal side effects of GLP-1 receptor agonists in obesity: Recommendations for clinical practice, Postgrad Med, 134, 14, 10.1080/00325481.2021.2002616 · DOI · Paper page

Cited by

See all 69

Metadata

Authors
Johnson, B., Milstead, M., Thomas, O., McGlasson, T., Green, L., Kreider, R., & Jones, R.
Corresponding author
Johnson, Brittany
Venue
Frontiers in Nutrition
Published
2025-04-25
Volume
12
Pages
1566498-1566498
ISSN
2296-861X (ISSN-L)
OpenAlex
W4409825229
Cited by
64
References
38
Citations by year
2026: 46 · 2025: 18
FWCI
36.19
Type
journal article
Language
en
Open access
Locations
  • Frontiers in Nutrition (publishedVersion, cc-by)
  • PubMed Central (publishedVersion, cc-by)
  • PubMed (publishedVersion)
  • DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
Topics
  • Health Sciences › Medicine › Pharmacology (medical) › Pharmacology and Obesity Treatment
  • Health Sciences › Nursing › Nutrition and Dietetics › Nutrition, Health and Food Behavior
  • Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Diabetes Treatment and Management
Keywords
GLP-1 receptor agonists, nutrient intake, obesity treatment, Dietary Reference Intakes, MyPlate, dietary fiber, calcium intake, iron intake, dietary magnesium, potassium intake, vitamin D, saturated fat, macronutrient distribution, food diary, micronutrient adequacy, dietary adherence, anti-obesity drugs

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Investigating nutrient intake during use of glucagon-like peptide-1 receptor agonist: a cross-sectional study. https://app.cochat.ai/papers/10.3389/fnut.2025.1566498
The paper
Johnson, B., Milstead, M., Thomas, O., McGlasson, T., Green, L., Kreider, R., & Jones, R. (2025). Investigating nutrient intake during use of glucagon-like peptide-1 receptor agonist: a cross-sectional study. Frontiers in Nutrition. https://doi.org/10.3389/fnut.2025.1566498

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.